Mesoblast (MESO) Free Cash Flow Growth (1y) (2017 - 2023)
Mesoblast (MESO) Free Cash Flow Growth (1y) (2017 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
88.70% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-15.72% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
66.37% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Mesoblast |
21.68 Bn |
21.55 Bn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
6.30% |
| Mar 31, 2023 |
5.04% |
| Dec 31, 2022 |
190.31% |
| Sep 30, 2022 |
-21.50% |
| Jun 30, 2022 |
35.55% |
| Mar 31, 2022 |
-88.89% |
| Dec 31, 2021 |
40.42% |
| Sep 30, 2021 |
164.61% |
| Jun 30, 2021 |
-109.38% |
| Mar 31, 2021 |
599.61% |
| Dec 31, 2020 |
-2,399.25% |
| Sep 30, 2020 |
-281.05% |
| Jun 30, 2020 |
9.63% |
| Mar 31, 2020 |
-6.11% |
| Dec 31, 2019 |
165.55% |
| Sep 30, 2019 |
-20.40% |
| Jun 30, 2019 |
25.68% |
| Mar 31, 2019 |
8.09% |
| Dec 31, 2018 |
-103.65% |
| Sep 30, 2018 |
196.01% |
